The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Surgical Tumor Ablation Market Research Report 2024
Synopsis
Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates.
The global Surgical Tumor Ablation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Surgical Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Tumor Ablation.
Report Scope
The Surgical Tumor Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Surgical Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Tumor Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Galil Medical
Misonix
HealthTronics
AngioDynamics
Medtronic
Boston Scientific Corporation
Medtronic
SonaCare Medical
EDAP TMS
NeuWave Medical
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
Segment by Application
Liver Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Tumor Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates.
The global Surgical Tumor Ablation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Surgical Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Tumor Ablation.
Report Scope
The Surgical Tumor Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Surgical Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Tumor Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Galil Medical
Misonix
HealthTronics
AngioDynamics
Medtronic
Boston Scientific Corporation
Medtronic
SonaCare Medical
EDAP TMS
NeuWave Medical
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
Segment by Application
Liver Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Tumor Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Surgical Tumor Ablation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Surgical Tumor Ablation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Surgical Tumor Ablation Market Perspective (2019-2030)
2.2 Surgical Tumor Ablation Growth Trends by Region
2.2.1 Global Surgical Tumor Ablation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Surgical Tumor Ablation Historic Market Size by Region (2019-2024)
2.2.3 Surgical Tumor Ablation Forecasted Market Size by Region (2025-2030)
2.3 Surgical Tumor Ablation Market Dynamics
2.3.1 Surgical Tumor Ablation Industry Trends
2.3.2 Surgical Tumor Ablation Market Drivers
2.3.3 Surgical Tumor Ablation Market Challenges
2.3.4 Surgical Tumor Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Surgical Tumor Ablation Players by Revenue
3.1.1 Global Top Surgical Tumor Ablation Players by Revenue (2019-2024)
3.1.2 Global Surgical Tumor Ablation Revenue Market Share by Players (2019-2024)
3.2 Global Surgical Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Surgical Tumor Ablation Revenue
3.4 Global Surgical Tumor Ablation Market Concentration Ratio
3.4.1 Global Surgical Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Surgical Tumor Ablation Revenue in 2023
3.5 Surgical Tumor Ablation Key Players Head office and Area Served
3.6 Key Players Surgical Tumor Ablation Product Solution and Service
3.7 Date of Enter into Surgical Tumor Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Surgical Tumor Ablation Breakdown Data by Type
4.1 Global Surgical Tumor Ablation Historic Market Size by Type (2019-2024)
4.2 Global Surgical Tumor Ablation Forecasted Market Size by Type (2025-2030)
5 Surgical Tumor Ablation Breakdown Data by Application
5.1 Global Surgical Tumor Ablation Historic Market Size by Application (2019-2024)
5.2 Global Surgical Tumor Ablation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Surgical Tumor Ablation Market Size (2019-2030)
6.2 North America Surgical Tumor Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Surgical Tumor Ablation Market Size by Country (2019-2024)
6.4 North America Surgical Tumor Ablation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Surgical Tumor Ablation Market Size (2019-2030)
7.2 Europe Surgical Tumor Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Surgical Tumor Ablation Market Size by Country (2019-2024)
7.4 Europe Surgical Tumor Ablation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Surgical Tumor Ablation Market Size (2019-2030)
8.2 Asia-Pacific Surgical Tumor Ablation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Surgical Tumor Ablation Market Size by Region (2019-2024)
8.4 Asia-Pacific Surgical Tumor Ablation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Surgical Tumor Ablation Market Size (2019-2030)
9.2 Latin America Surgical Tumor Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Surgical Tumor Ablation Market Size by Country (2019-2024)
9.4 Latin America Surgical Tumor Ablation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Surgical Tumor Ablation Market Size (2019-2030)
10.2 Middle East & Africa Surgical Tumor Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Surgical Tumor Ablation Market Size by Country (2019-2024)
10.4 Middle East & Africa Surgical Tumor Ablation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galil Medical
11.1.1 Galil Medical Company Detail
11.1.2 Galil Medical Business Overview
11.1.3 Galil Medical Surgical Tumor Ablation Introduction
11.1.4 Galil Medical Revenue in Surgical Tumor Ablation Business (2019-2024)
11.1.5 Galil Medical Recent Development
11.2 Misonix
11.2.1 Misonix Company Detail
11.2.2 Misonix Business Overview
11.2.3 Misonix Surgical Tumor Ablation Introduction
11.2.4 Misonix Revenue in Surgical Tumor Ablation Business (2019-2024)
11.2.5 Misonix Recent Development
11.3 HealthTronics
11.3.1 HealthTronics Company Detail
11.3.2 HealthTronics Business Overview
11.3.3 HealthTronics Surgical Tumor Ablation Introduction
11.3.4 HealthTronics Revenue in Surgical Tumor Ablation Business (2019-2024)
11.3.5 HealthTronics Recent Development
11.4 AngioDynamics
11.4.1 AngioDynamics Company Detail
11.4.2 AngioDynamics Business Overview
11.4.3 AngioDynamics Surgical Tumor Ablation Introduction
11.4.4 AngioDynamics Revenue in Surgical Tumor Ablation Business (2019-2024)
11.4.5 AngioDynamics Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Surgical Tumor Ablation Introduction
11.5.4 Medtronic Revenue in Surgical Tumor Ablation Business (2019-2024)
11.5.5 Medtronic Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Surgical Tumor Ablation Introduction
11.6.4 Boston Scientific Corporation Revenue in Surgical Tumor Ablation Business (2019-2024)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Surgical Tumor Ablation Introduction
11.7.4 Medtronic Revenue in Surgical Tumor Ablation Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 SonaCare Medical
11.8.1 SonaCare Medical Company Detail
11.8.2 SonaCare Medical Business Overview
11.8.3 SonaCare Medical Surgical Tumor Ablation Introduction
11.8.4 SonaCare Medical Revenue in Surgical Tumor Ablation Business (2019-2024)
11.8.5 SonaCare Medical Recent Development
11.9 EDAP TMS
11.9.1 EDAP TMS Company Detail
11.9.2 EDAP TMS Business Overview
11.9.3 EDAP TMS Surgical Tumor Ablation Introduction
11.9.4 EDAP TMS Revenue in Surgical Tumor Ablation Business (2019-2024)
11.9.5 EDAP TMS Recent Development
11.10 NeuWave Medical
11.10.1 NeuWave Medical Company Detail
11.10.2 NeuWave Medical Business Overview
11.10.3 NeuWave Medical Surgical Tumor Ablation Introduction
11.10.4 NeuWave Medical Revenue in Surgical Tumor Ablation Business (2019-2024)
11.10.5 NeuWave Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
